Don't Miss It: Hot Deals & Firms We Followed This Week

Law360, New York (July 14, 2017, 7:29 PM EDT) -- With so much mergers and acquisitions news this week, you may have missed several deals announced in recent days helmed by firms such as Weil and O'Melveny & Myers.

Here, Law360 recaps the ones you might have missed.

Emergent BioSolutions Inc. has agreed to buy the only smallpox vaccine licensed by the U.S. Food and Drug Administration for $125 million, according to a Friday statement. The seller is a unit of France-based Sanofi SA.

The deal sees Emergent BioSolutions scoop up the ACAM2000 business of Sanofi for $97.5 million upfront and as much as $27.5 million in near-term contingent regulatory and...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS